Friday, December 15, 2017 1:03:43 PM
But a reverse split will help them get back to the Nasdaq, which I think is what they're aiming for.
Another interesting point ... this company has successfully regenerated a human organ and yet this news is still flying under the radar. The penny stock enthustiasts haven't yet picked up or piled on to this one. Hopefully that will change before the RS.
Recent HRGN News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:47:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 07:04:40 PM
- Approval of Orphan Disease Application for this Biotech Firm • AllPennyStocks.com • 08/21/2023 03:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM